Essential Lab Tests and Key Markers for Effective TRT Monitoring

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

TRT requires regular lab testing of total and free testosterone, LH/FSH, hematocrit, PSA, lipids, and liver function to ensure safety and effective dosing. Monitoring helps detect side effects like erythrocytosis and prostate issues.

# Lab Testing for TRT: Essential Markers

Testosterone Replacement Therapy (TRT) is a widely used treatment for men with low testosterone levels, aimed at restoring hormonal balance and improving quality of life. However, TRT requires careful monitoring through lab testing to ensure safety, efficacy, and optimal dosing. This article explores the essential lab markers involved in TRT management, outlining practical protocols and evidence-based guidelines for healthcare providers and patients.

Understanding the Role of Lab Testing in TRT

TRT is not a “set it and forget it” therapy. Hormonal balance is complex, and the introduction of exogenous testosterone affects multiple physiological systems. Lab testing helps:

  • Confirm low testosterone before starting treatment
  • Guide dosing adjustments during therapy
  • Monitor for potential side effects or complications
  • Assess overall health status related to TRT

    • Regular monitoring maximizes benefits while minimizing risks such as erythrocytosis, prostate issues, or lipid abnormalities.

    ---

    Essential Hormonal Markers to Monitor

    Total Testosterone

    What it measures: Total testosterone quantifies the combined amount of free and protein-bound testosterone circulating in the blood.

    Why it matters: Diagnosing hypogonadism requires documenting low total testosterone levels, typically below 300 ng/dL (nanograms per deciliter) on morning fasting blood tests. After starting TRT, total testosterone levels guide dose titration.

    Testing protocol:

  • Draw blood between 7-10 AM when testosterone levels peak naturally.
  • Use reliable assays such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) for accuracy.
  • Repeat after 3-6 weeks of initiating or adjusting TRT to assess response.

    • Free Testosterone

    What it measures: Free testosterone is the biologically active, unbound fraction available to tissues.

    Why it matters: In some cases, total testosterone may appear normal while free testosterone is low, especially in conditions with altered sex hormone-binding globulin (SHBG) levels (e.g., obesity, diabetes). Free testosterone measurement offers additional insight.

    Testing protocol:

  • Can be measured directly or calculated using total testosterone, SHBG, and albumin levels.
  • Useful in borderline or complex cases.

    • Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH)

    What they measure: LH and FSH are pituitary hormones that stimulate the testes.

    Why it matters: These markers help differentiate primary hypogonadism (testicular failure with elevated LH/FSH) from secondary hypogonadism (pituitary or hypothalamic dysfunction with low/normal LH/FSH). TRT typically suppresses LH and FSH, confirming adequate exogenous testosterone dosing.

    ---

    Safety and Side Effect Monitoring

    Hematocrit and Hemoglobin

    Why monitor: TRT can stimulate red blood cell production, increasing hematocrit and hemoglobin. Excessive elevation (>54% hematocrit) raises the risk of blood clots, stroke, and cardiovascular events.

    Testing protocol:

  • Check baseline hematocrit and hemoglobin before TRT.
  • Repeat at 3 months, then every 6-12 months.
  • If hematocrit exceeds 54%, consider dose adjustment, therapeutic phlebotomy, or temporary discontinuation.

    • Prostate-Specific Antigen (PSA)

    Why monitor: Testosterone can stimulate prostate tissue growth. PSA is a marker used to screen for prostate cancer or benign prostatic hyperplasia.

    Testing protocol:

  • Screen PSA levels prior to starting TRT.
  • Reassess at 3-6 months, then annually.
  • Any significant increase warrants urological evaluation.

    • Liver Function Tests (LFTs)

    Why monitor: Although injectable TRT has minimal liver impact, oral formulations may affect liver enzymes.

    Testing protocol:

  • Baseline LFTs are recommended before TRT initiation.
  • Monitor periodically if oral testosterone or additional medications are used.

    • Lipid Profile

    Why monitor: TRT may influence cholesterol and triglyceride levels, potentially impacting cardiovascular risk.

    Testing protocol:

  • Assess fasting lipid profile before treatment.
  • Follow up every 6-12 months during therapy.

    • ---

    Practical TRT Lab Testing Protocol

    | Timepoint | Tests to Order |

    |------------------------|--------------------------------------------------|

    | Baseline (Pre-TRT) | Total Testosterone, Free Testosterone, LH, FSH, PSA, Hematocrit/Hemoglobin, Lipid Panel, LFTs |

    | 3-6 Weeks Post-Start | Total Testosterone, Hematocrit/Hemoglobin |

    | 3-6 Months Post-Start | Total Testosterone, PSA, Hematocrit/Hemoglobin, Lipid Panel |

    | Every 6-12 Months | Total Testosterone, PSA, Hematocrit/Hemoglobin, Lipid Panel, LFTs (if indicated